Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. März 2026 16:05 ET | Quelle: Lyell Immunopharma, Inc

Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal...
12. März 2026 11:55 ET | Quelle: Research and Markets

Pharmaceuticals and Biotechnology Joint Venture Terms and Agreement Analysis Report 2026: Valuable Insights Into Deal Structures, Financial Terms, and Partnership Strategies

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026" report has been added to ResearchAndMarkets.com's offering.The Joint Venture...
12. März 2026 11:46 ET | Quelle: Research and Markets

Pharmaceuticals and Biotechnology Asset Purchase Agreements Report 2026 and Directory of Deals Signed Since 2019 by the World's Leading Life Science Companies

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering.The Asset Purchase...
12. März 2026 11:27 ET | Quelle: Research and Markets

Biotechnology Collaboration Agreements Report 2026 with Directory of 2,000+ Deals Signed Since 2020 - Access Real Contract Documents and Identify the Most Active Dealmakers

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering.The Collaboration Deals in Biotechnology...
12. März 2026 10:54 ET | Quelle: Research and Markets

Biotechnology Licensing Agreements Trends Report 2026 with Directory of 2,500+ Deals Signed Since 2020 by the World's Leading Biopharma Companies

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Licensing Deals in Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering.The Licensing Deals in Biotechnology 2020-2026...
12. März 2026 10:41 ET | Quelle: Research and Markets

Pharmaceuticals and Biotechnology Co-promotion and Co-marketing Agreements Trends Report 2026 with Directory of 384 Deal Records - Terms, Structures, and Strategies Behind These Impactful Partnerships

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2026" report has been added to ResearchAndMarkets.com's offering. Whether...
12. März 2026 09:00 ET | Quelle: Trinity Biotech plc

Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System

Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointment DUBLIN, March 12, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech...
11. März 2026 08:00 ET | Quelle: George Medicines

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea GMRx2 is an innovative single pill combination of three medicines designed to deliver...
10. März 2026 14:00 ET | Quelle: Custom Market Insights

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

Global Pharmaceutical Microbiology QC Testing Market grows as demand rises for sterility, bioburden, and endotoxin testing in pharmaceutical and biologics.
10. März 2026 10:44 ET | Quelle: PolTREG S.A.

PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes

The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDAŃSK, Poland,...

Nächste Seite